Detalhe da pesquisa
1.
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1.
Mol Cell
; 71(4): 606-620.e7, 2018 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30118680
2.
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer.
Breast Cancer Res Treat
; 199(3): 457-469, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37061619
3.
Quantitative Apparent Diffusion Coefficients From Peritumoral Regions as Early Predictors of Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.
J Magn Reson Imaging
; 56(6): 1901-1909, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35499264
4.
Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC).
Breast Cancer Res Treat
; 185(1): 1-12, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32920733
5.
A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer.
Invest New Drugs
; 39(2): 509-515, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32984932
6.
Functional Tumor Volume by Fast Dynamic Contrast-Enhanced MRI for Predicting Neoadjuvant Systemic Therapy Response in Triple-Negative Breast Cancer.
J Magn Reson Imaging
; 54(1): 251-260, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33586845
7.
Comparison of three scoring methods using the FDA-approved 22C3 immunohistochemistry assay to evaluate PD-L1 expression in breast cancer and their association with clinicopathologic factors.
Breast Cancer Res
; 22(1): 69, 2020 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32576238
8.
A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment.
Br J Cancer
; 120(12): 1105-1112, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31097774
9.
Adaptive Randomization of Neratinib in Early Breast Cancer.
N Engl J Med
; 375(1): 11-22, 2016 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27406346
10.
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
N Engl J Med
; 375(1): 23-34, 2016 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27406347
11.
Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1).
Breast Cancer Res Treat
; 176(1): 227-234, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30977027
12.
Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study.
Invest New Drugs
; 37(2): 345-351, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30610588
13.
Development of CNS metastases and survival in patients with inflammatory breast cancer.
Cancer
; 124(11): 2299-2305, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29579338
14.
Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast Cancer.
Oncologist
; 23(11): 1300-1309, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30139837
15.
A phase II study of imatinib mesylate and letrozole in patients with hormone receptor-positive metastatic breast cancer expressing c-kit or PDGFR-ß.
Invest New Drugs
; 36(6): 1103-1109, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30311036
16.
A phase II study of tipifarnib and gemcitabine in metastatic breast cancer.
Invest New Drugs
; 36(2): 299-306, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29374384
17.
Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field.
Oncologist
; 22(9): 1086-1093, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28559413
18.
Performance of Mid-Treatment Breast Ultrasound and Axillary Ultrasound in Predicting Response to Neoadjuvant Chemotherapy by Breast Cancer Subtype.
Oncologist
; 22(4): 394-401, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28314842
19.
Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy.
Cancer
; 121(24): 4324-32, 2015 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26348887
20.
Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer.
Breast Cancer Res Treat
; 152(2): 347-56, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26109346